PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 52 filers reported holding PHOENIX BIOTECH ACQUISITION in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 163,538 | $1,639,000 | 0.08% |
| Radcliffe Capital Management, L.P. | 150,000 | $1,503,000 | 0.04% |
| Telemetry Investments, L.L.C. | 125,114 | $13,000 | 0.02% |
| Q Global Advisors, LLC | 170,785 | $17,000 | 0.01% |
| Atalaya Capital Management LP | 225,000 | $25,000 | 0.00% |
| MMCAP International Inc. SPC | 375,000 | $38,000 | 0.00% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 677,408 | $88,000 | 0.00% |
| Alpine Global Management, LLC | 55,100 | $6,000 | 0.00% |
| Sage Rock Capital Management LP | 91,999 | $9,000 | 0.00% |
| Bulldog Investors, LLP | 51,757 | $5,000 | 0.00% |